Form 144: Proposed sale of SGRY shares by UBS (NASDAQ: SGRY)

Rhea-AI Filing Summary

UBS Financial Services Inc filed a Form 144 notice for proposed sales of common stock of Surgery Partners, Inc. (SGRY). The filing lists equity-vesting related shares: 5,291 shares vested 02/28/2026 and 6,171 shares vested 03/02/2026. The filing date shown is 03/06/2026 and the listing venue is NASDAQ.

Insights

Compliance Counsel

Routine Form 144 notice for proposed insider resale transactions.

This Form 144 discloses proposed sales tied to equity vesting events: 5,291 shares (02/28/2026) and 6,171 shares (03/02/2026). The broker/filing intermediary is UBS Financial Services Inc.

These notices are administrative and do not confirm completed sales; reported dates and share counts are the operative facts in this excerpt.

FAQ

What does the Form 144 filed for SGRY mean?

It notifies the SEC of proposed insider sales of SGRY common shares. The excerpt lists proposed sales tied to equity vesting: 5,291 shares on 02/28/2026 and 6,171 shares on 03/02/2026; it does not confirm completion of any sale.

Who submitted the Form 144 for SGRY shares?

UBS Financial Services Inc is listed as the filing intermediary. The excerpt identifies UBS at an address in Weehawken, NJ and shows the filing linked to NASDAQ with a filing date of 03/06/2026.

How many SGRY shares are listed in the Form 144 excerpt?

The excerpt lists two vesting-related share amounts totaling the reported items: 5,291 shares vested on 02/28/2026 and 6,171 shares vested on 03/02/2026. The filing does not state whether these shares were actually sold.

Does the Form 144 confirm sales were executed for SGRY?

No — Form 144 is a notice of proposed sales, not proof of execution. The provided excerpt shows proposed/vesting-related quantities and dates; it does not document completed transactions or proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 12:51 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001670094
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Surgery Partners, Inc.
SEC File Number	001-37576
Address of Issuer	340 Seven Springs Way, Suite 600 Brentwood TENNESSEE 37027
Phone	(615) 234-5900
Name of Person for Whose Account the Securities are To Be Sold	Jason Eric Evans
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	11462	158099.71	129419836	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/28/2026	equity vesting	Surgery Partners, Inc.			5291	02/28/2026	equity compensation
common	03/02/2026	equity vesting	Surgery Partners, Inc.			6171	03/02/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Jason Eric Evans
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)